2:27 am AstraZeneca receives FDA approval for Bydureon Pen for once-weekly treatment of adults with Type 2 Diabetes
View todays social media effects on AZN
View the latest stocks trending across Twitter. Click to view dashboard
See who Astrazeneca is hiring next, click here to view
